The ability to engineer an antibody that specifically binds two epitopes shows promise for therapeutic and diagnostic applications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
Nature Communications Open Access 30 July 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Garcia, C. et al. Nat. Biotechnol. 25, 107–116 (2007)
Casadevall, A., Dadachova, E. & Pirofski, L. Nat. Rev. Microbiol. 2, 695–703 (2004).
Buchwald, U.K. & Pirofski, L. Curr. Pharm. Des. 9, 945–968 (2003).
Bregenholt, S. et al. Curr. Pharm. Des. 12, 2007–2015 (2006).
Bakker, A.B.H. et al. J. Virol. 79, 9062–9068 (2005).
Hanson, B.J. et al. Respir. Res. 7, 126 (2006).
Pantophlet, R. & Burton, D.R. Annu. Rev. Immunol. 24, 739–769 (2006).
Zhang, M-Y . et al. J. Mol. Biol. 335, 209–219 (2004).
Jonah, G., Rainey, A. & Young, J.A.T. Nat. Rev. Microbiol. 2, 721–726 (2004).
Sethuraman, N. & Stadheim, T.A. Curr. Opin. Biotechnol. 17, 341–346 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Presta, L. Evolving an anti-toxin antibody. Nat Biotechnol 25, 63–65 (2007). https://doi.org/10.1038/nbt0107-63
Issue Date:
DOI: https://doi.org/10.1038/nbt0107-63
This article is cited by
-
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
Nature Communications (2022)